Measurement of inhibin A and activin A in pregnancy - Possible diagnostic applications

Molecular and Cellular Endocrinology

Volumn 180, Issue 1-2, 2001, Pages 117-121

  Ledger, William L ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Activin A; Inhibin A; Pregnancy

Indexed keywords

ACTIVIN A; INHIBIN A;

AMNION FLUID; ARTICLE; DOWN SYNDROME; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SERUM;

ACTIVINS; DOWN SYNDROME; FEMALE; HUMANS; INHIBINS; OBSTETRIC LABOR, PREMATURE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL DIAGNOSIS;

EID: 0035974424     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(01)00512-3     Document Type: Article

References (38)

1. Longitudinal analysis of plasma leptin concentrations during normal pregnancy and pre-eclampsia
2. Second trimester maternal serum inhibin A concentrations as an early marker for pre-eclampsia
3. Inhibin and related peptides in the regulation of reproduction
4. Inhibin A and activin A in the first trimester of human pregnancy
5. Maternal serum inhibin A can predict pre-eclampsia
6. Increased maternal serum activin A but not follistatin levels in pregnant women with hypertensive disorders
7. A longitudinal study of maternal serum inhibin-A, inhibin-B, activin-A, activin-AB, pro-α-C and follistatin during pregnancy
8. Inhibin-A and pro-α-C are elevated in pre-eclamptic pregnancy and correlate with human chorionic gonadotropin
9. Serum levels of activin A and inhibin A and the subsequent development of pre-eclampsia
10. Measurement of circulating inhibin forms during the establishment of pregnancy
11. Pharmacologic 'rescue' of the corpus luteum results in increased inhibin production
12. Serum activin A and inhibin A elevated in pre-eclampsia: no relation to insulin sensitivity
13. Identification of the source of inhibins at the time of conception provides a diagnostic role for them in very early pregnancy
14. Circulating inhibins and activin-A during GnRH downregulation and ovarian hyperstimulation with recombinant FSH for in vitro fertilisation-embryo transfer
15. Inhibin pro-α-C and the prediction of OHSS in IVF treatment
16. Gonadal and extragonadal expression of inhibin α, βA and βB subunits in various tissues predicts diverse functions
17. Immunohistochemical localisation of inhibin/activin subunits in human placenta
18. Measurement of serum concentrations of inhibin A (α-βA dimer) during human pregnancy
19. Serum concentrations of 'total' activin A during the human menstrual cycle and pregnancy
20. Activin A and inhibin A as possible endocrine markers for pre-eclampsia
21. Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia
22. Maternal serum inhibin-A and free beta-hCG concentrations in trisomy 21 pregnancies at 10 to 14 weeks of gestation
23. Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia
24. Abnormal concentration of maternal serum activin-A in gestational diseases
25. High levels of fetal membrane activin beta A and activin receptor IIB mRNAs and augmented concentration of amniotic fluid activin A in women in term or preterm labor
26. Inhibin subunits in human placenta: localization and messenger ribonucleic acid levels during pregnancy
27. Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free beta-hCG levels
28. Current topic, pre-eclampsia and the placenta
29. Management of pre-eclampsia
30. Dimeric inhibin A and alpha-subunit immunoreactive material in maternal serum during spontaneous and in vitro fertilization pregnancies
31. Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies
32. Maternal serum inhibin A concentrations in early pregnancy after IVF and embryo transfer reflect the corpus luteum contribution and pregnancy outcome
33. Immunoradiometric assay for follistatin: serum immunoreactive follistatin levels in normal adults and pregnant women
34. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. International Prenatal Screening Research Group
35. Amniotic fluid inhibin-A in chromosomally normal and Down's syndrome pregnancies
36. Evaluation of maternal serum dimeric inhibin A as a first trimester marker of Down's syndrome
37. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A
38. Concentrations of immunoreactive inhibin in serum during human pregnancy: evidence for an ovarian contribution